Articles From: InterAmerican Gaming Provides Corporate Update to IntercontinentalExchange Sets Daily Volume Record in ICE U.S. Dollar Index


2013/4/9
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0865513001&sourceType=1 TORONTO, ONTARIO --
Sign-up for InterAmerican Gaming Provides Corporate Update investment picks
2013/3/18
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0860605001&sourceType=1 TORONTO, ONTARIO --
Sign-up for InterAmerican Gaming Unveils Version 2.0 of the SoFit Platform investment picks
2013/5/8
InterCall ®, a subsidiary of West Corporation, and the world's largest conferencing and collaboration services provider , announced today the availability of Unified Meeting® 5, the latest version of its web-based conferencing product.
Sign-up for InterCall Unified Meeting® 5 Enhances Meeting Performance investment picks
2013/5/14
Intercede , the producer of MyID ® and a world leader in identity and credential management systems, today announced that the company’s chief technology officer, Chris Edwards, and vice president of business development, Peter Cattaneo, will be presenting at the Smart Card Alliance’s (SCA) annual NFC Solutions Summit, on May 14 and 16 in Burlingame, Calif.
Sign-up for Intercede Executives to Discuss Authenticated Identity at NFC Solutions Summit 2013 investment picks
2013/4/8
Intercede , the producer of MyID ® and a world leader in identity and credential management systems, today announced that Peter Cattaneo, vice president of business development, will be presenting at Smart Card Alliance’s Mobile Devices and Identity and Access Control Applications Workshop at ISC West 2013, on April 9 in Las Vegas.
Sign-up for Intercede to Discuss CIV Credentials on Mobile Devices at ISC West 2013 investment picks
2013/3/18
Continued Development Progress and a Strong Cash Position   Conference Call Scheduled Today at 5:30 p.m. ET NEW YORK, March 18, 2013 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver diseases, today reported financial results for the fourth quarter and full year ended December 31, 2012 and provided an update on corporate developments.
Sign-up for Intercept Pharmaceuticals Announces 2012 Financial Results and Provides Business Update investment picks
2013/4/30
NEW YORK, April 30, 2013 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) , a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases, today announced additional details relating to the analysis presented by the Global Primary Biliary Cirrhosis Study Group (Study Group) at the annual meeting of the European Association for the Study of the Liver (EASL) held in Amsterdam on April 24-28, 2013.
Sign-up for Intercept Pharmaceuticals Announces Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis Presented at EASL investment picks
2013/5/20
NEW YORK , May 20, 2013 /PRNewswire/ --  Intercept Pharmaceuticals, Inc. ("Intercept", NASDAQ: ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases, today announced positive initial results from OBADIAH, an ongoing Phase 2a trial of obeticholic acid (OCA) as a treatment for primary bile acid diarrhea (PBAD) presented at the Digestive Diseases Week conference.
Sign-up for Intercept Pharmaceuticals Announces Positive Initial Results from Ongoing Phase 2a Trial in Chronic Bile Acid Diarrhea investment picks
2013/4/8
NEW YORK, April 8, 2013 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) , a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases, today announced that an analysis by the Global Primary Biliary Cirrhosis (PBC) Study Group (also known as the PBC Supergroup) confirms that the endpoint used by Intercept in its ongoing Phase 3 POISE trial is strongly predictive of adverse clinical outcomes in PBC patients.
Sign-up for Intercept Pharmaceuticals Announces Upcoming EASL Presentation investment picks
2013/3/12
NEW YORK, March 12, 2013 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver diseases, today announced that it will report 2012 fourth quarter and full year financial results after the NASDAQ Market closes on Monday, March 18, 2013.
Sign-up for Intercept Pharmaceuticals to Host 2012 Fourth Quarter and Full Year Financial Results Conference Call on March 18 investment picks
2013/5/23
NEW YORK , May 23, 2013 /PRNewswire/ -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver diseases, such as primary biliary cirrhosis, today announced that Mark Pruzanski , MD, President and Chief Executive Officer, will present at the Deutsche Bank Securities 38th Annual Health Care Conference in Boston on Wednesday, May 29, 2013 at 4:10 p.m. ET .
Sign-up for Intercept Pharmaceuticals to Present at Deutsche Bank Healthcare Conference investment picks
2013/2/25
NEW YORK, Feb.
Sign-up for Intercept Pharmaceuticals to Present at the Cowen and Company 33rd Annual Healthcare Conference investment picks
2013/4/25
NEW YORK, April 25, 2013 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver diseases, such as primary biliary cirrhosis, today announced that Mark Pruzanski, MD, President and Chief Executive Officer, will present at the following investor conferences in May: Live and archived audio webcasts of the company's sessions will be available on the "Events" section of Intercept's investor website at http://ir.interceptpharma.com .
Sign-up for Intercept Pharmaceuticals to Present at Upcoming Healthcare Conferences investment picks
2013/3/28
BOCA RATON, Fla., March 28, 2013 (GLOBE NEWSWIRE) -- Ludlow Research, an equity research firm based in New York, has placed InterCloud Systems, Inc. (OTCBB:ICLD) on 'earnings watch' based on pending fiscal 2012 financial results.
Sign-up for InterCloud Systems Placed on 'Earnings Watch' investment picks
2013/5/17
BOCA RATON, Fla., May 17, 2013 (GLOBE NEWSWIRE) -- InterCloud Systems Inc. (OTCBB:ICLD) ("InterCloud"), an end-to-end solution provider of professional services and infrastructure services to the telecommunications industry, major corporations and governmental entities, today announced financial results for the first quarter ended March 31, 2013.
Sign-up for InterCloud Systems Reports First Quarter 2013 Results investment picks
2013/4/4
BOCA RATON, Fla., April 4, 2013 (GLOBE NEWSWIRE) -- InterCloud Systems Inc. (OTCBB:ICLD) ("InterCloud"), an end-to-end solution provider of professional services and infrastructure to the telecommunications industry, major corporations and governmental entities, today announced results for the fourth quarter and full year ended December 31, 2012.
Sign-up for InterCloud Systems Reports Fourth Quarter and Full Year 2012 Results investment picks
2013/4/9
BOCA RATON, Fla., April 9, 2013 (GLOBE NEWSWIRE) -- InterCloud Systems, Inc. (OTCBB:ICLD) , an end-to-end solution provider of cloud and managed services, professional services, infrastructure and applications to the telecommunications industry, major corporations and governmental entities, announced that it has signed a definitive agreement to acquire AW Solutions, Inc. (AWS) of Longwood, Florida for an aggregate purchase price of $5,215,607.50, subject to certain adjustments, consisting of cash, promissory notes and InterCloud common stock, which such aggregate amount represents two and one-half times AWS's reported EBITDA for the period from March 1, 2012 to February 28, 2013.
Sign-up for InterCloud Systems to Acquire AW Solutions investment picks
2013/5/20
ATLANTA , May 20, 2013 /PRNewswire/ -- IntercontinentalExchange (NYSE: ICE) , a leading operator of global markets and clearing houses, announced today the result of the company's 2013 Annual Meeting of Stockholders, which was held May 17, 2013 .
Sign-up for IntercontinentalExchange Announces 2013 Annual Meeting Results investment picks
2013/4/12
LONDON , April 12, 2013 /PRNewswire/ -- IntercontinentalExchange (NYSE: ICE) , a leading operator of global markets and clearing houses, today announced the introduction of 35 new energy, environmental, freight and ferrous metal contracts on April 29, 2013 .
Sign-up for IntercontinentalExchange Announces April 29 Launch of 35 New Futures Contracts investment picks
2013/6/10
CHICAGO , June 10, 2013 /PRNewswire/ -- IntercontinentalExchange (NYSE: ICE) , a leading operator of global markets and clearing houses, today announced that as of June 6 it has cleared more than $1 trillion in credit default swap (CDS) gross notional value by buyside participants since client clearing was launched in December 2009.
Sign-up for IntercontinentalExchange Announces Buyside Clearing Surpasses $1 Trillion in CDS Gross Notional investment picks
2013/4/12
LONDON , April 12, 2013 /PRNewswire/ -- IntercontinentalExchange (NYSE: ICE) , a leading operator of global markets and clearing houses, today announced a daily volume record of 35,733 contracts was reached in ICE Heating Oil futures on April 11, 2013 .
Sign-up for IntercontinentalExchange Announces Daily Volume Record in Heating Oil investment picks
2013/4/17
NEW YORK , April 17, 2013 /PRNewswire/ -- IntercontinentalExchange (NYSE: ICE) , a leading operator of global markets and clearing houses, announced today it will introduce two new Russell Index futures contracts.
Sign-up for IntercontinentalExchange Announces Launch of Russell 2000 Growth and Value Index Futures investment picks
2013/3/11
NEW YORK , March 11, 2013 /PRNewswire/ -- IntercontinentalExchange (NYSE: ICE) , a leading operator of global markets and clearing houses, announced today it will introduce four credit index futures contracts starting in May 2013 .
Sign-up for IntercontinentalExchange Announces May Launch of Credit Index Futures Contracts investment picks
2013/6/5
ATLANTA , June 5, 2013 /PRNewswire/ -- IntercontinentalExchange (NYSE: ICE) , a leading operator of global markets and clearing houses, announced today that Jeffrey C.
Sign-up for IntercontinentalExchange Chairman and CEO to Present at Sandler O'Neill's Global Exchange Conference on June 7 investment picks
2013/5/1
- 1Q13 GAAP Diluted EPS of $1.85 - 1Q13 GAAP Net Income Attributable to ICE of $135MM - 1Q13 Revenues of $352MM ATLANTA , May 1, 2013 /PRNewswire/ -- IntercontinentalExchange (NYSE: ICE) , a leading operator of global markets and clearing houses, today reported financial results for the first quarter of 2013.
Sign-up for IntercontinentalExchange Reports 1Q13 Adjusted Diluted EPS Of $2.03, Adjusted Net Income Attributable To ICE Of $149MM investment picks
2013/6/7
NEW YORK , June 7, 2013 /PRNewswire/ -- IntercontinentalExchange (NYSE: ICE) , a leading operator of global markets and clearing houses, today reported record daily volume in the ICE U.S. Dollar Index (USDX) futures contract of 116,372 contracts on June 6, 2013 .
Sign-up for IntercontinentalExchange Sets Daily Volume Record in ICE U.S. Dollar Index investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: InterAmerican Gaming Provides Corporate Update to IntercontinentalExchange Sets Daily Volume Record in ICE U.S. Dollar Index
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity